Skip to main content
. 2020 Sep 25;18:304. doi: 10.1186/s12916-020-01724-5

Fig. 5.

Fig. 5

Odds of clinical malaria by compound sero-prevalence (a) and odds of asymptomatic infection by compound sero-prevalence (b). Analyses is adjusted for age group (< 5 years, 5–15 years, and > 15 years) and LLIN use in the last 24 h and weighted by compound size